Clinical trial
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Mexiletine for Painful Diabetic Neuropathy
NCT00004647 is registered in ClinicalTrials.gov with National Center for Research Resources (NCRR) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Mexiletine for Painful Diabetic Neuropathy
- Lead sponsor
- National Center for Research Resources (NCRR)
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 1993
- Completion date
- February 28, 1999
- Enrollment
- 40
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.